These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31203605)

  • 21. New hepatocytes for toxicology?
    Hartung T; Gribaldo L
    Trends Biotechnol; 2004 Dec; 22(12):613-5; discussion 615-6. PubMed ID: 15542148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood-brain barrier in vitro models and their application in toxicology. The report and recommendations of ECVAM Workshop 49.
    Prieto P; Blaauboer BJ; de Boer AG; Boveri M; Cecchelli R; Clemedson C; Coecke S; Forsby A; Galla HJ; Garberg P; Greenwood J; Price A; Tähti H;
    Altern Lab Anim; 2004 Mar; 32(1):37-50. PubMed ID: 15603552
    [No Abstract]   [Full Text] [Related]  

  • 23. Analytical toxicology.
    Maurer HH
    EXS; 2010; 100():317-37. PubMed ID: 20358688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immortalisation of primary cells.
    Stacey G; MacDonald C
    Cell Biol Toxicol; 2001; 17(4-5):231-46. PubMed ID: 11768592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality of biotechnological products: analysis of the expression construct in cell lines used for production of r-DNA derived protein products. ICH Harmonised Tripartite Guideline.
    Dev Biol Stand; 1998; 93():205-8. PubMed ID: 9737397
    [No Abstract]   [Full Text] [Related]  

  • 26. Breast cancer cell lines: friend or foe?
    Burdall SE; Hanby AM; Lansdown MR; Speirs V
    Breast Cancer Res; 2003; 5(2):89-95. PubMed ID: 12631387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Curbing rampant cross-contamination and misidentification of cell lines.
    Nardone RM
    Biotechniques; 2008 Sep; 45(3):221-7. PubMed ID: 18816888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Good Caco-2 cell culture practices.
    Natoli M; Leoni BD; D'Agnano I; Zucco F; Felsani A
    Toxicol In Vitro; 2012 Dec; 26(8):1243-6. PubMed ID: 22465559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. European Union revamps toxicology testing in attempt to limit animal use, improve prediction.
    Sinha G
    J Natl Cancer Inst; 2006 Jun; 98(11):728-9. PubMed ID: 16757693
    [No Abstract]   [Full Text] [Related]  

  • 30. [Good cell culture practice--implementation of a relational cell culture database].
    Philipp MO; Falkner E; Kapeller B; Eberl H; Frick W; Macfelda K; Losert UM
    ALTEX; 2002; 19(1):21-6. PubMed ID: 11927979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using Chromatin Immunoprecipitation in Toxicology: A Step-by-Step Guide to Increasing Efficiency, Reducing Variability, and Expanding Applications.
    McCullough SD; On DM; Bowers EC
    Curr Protoc Toxicol; 2017 May; 72():3.14.1-3.14.28. PubMed ID: 28463415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose metric considerations in in vitro assays to improve quantitative in vitro-in vivo dose extrapolations.
    Groothuis FA; Heringa MB; Nicol B; Hermens JL; Blaauboer BJ; Kramer NI
    Toxicology; 2015 Jun; 332():30-40. PubMed ID: 23978460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence-based toxicology - the toolbox of validation for the 21st century?
    Hartung T
    ALTEX; 2010; 27(4):253-63. PubMed ID: 21240468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Check your cultures! A list of cross-contaminated or misidentified cell lines.
    Capes-Davis A; Theodosopoulos G; Atkin I; Drexler HG; Kohara A; MacLeod RA; Masters JR; Nakamura Y; Reid YA; Reddel RR; Freshney RI
    Int J Cancer; 2010 Jul; 127(1):1-8. PubMed ID: 20143388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reproducibility: changing the policies and culture of cell line authentication.
    Freedman LP; Gibson MC; Ethier SP; Soule HR; Neve RM; Reid YA
    Nat Methods; 2015 Jun; 12(6):493-7. PubMed ID: 26020501
    [No Abstract]   [Full Text] [Related]  

  • 36. Comprehensive summary--Predict-IV: A systems toxicology approach to improve pharmaceutical drug safety testing.
    Mueller SO; Dekant W; Jennings P; Testai E; Bois F
    Toxicol In Vitro; 2015 Dec; 30(1 Pt A):4-6. PubMed ID: 25450741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A toxicologist's guide to studying diagnostic tests.
    Bailey B; Amre DK
    Clin Toxicol (Phila); 2005; 43(3):171-9. PubMed ID: 15902791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutagenesis assays in mammalian cells.
    Klein CB; Broday L; Costa M
    Curr Protoc Toxicol; 2001 May; Chapter 3():Unit3.3. PubMed ID: 20941701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A silver lining in cell line authentication: Short tandem repeat analysis of 1373 cases in China from 2010 to 2019.
    Gu M; Yang M; He J; Xia S; Zhang Z; Wang Y; Zheng C; Shen C
    Int J Cancer; 2022 Feb; 150(3):502-508. PubMed ID: 34469590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality control in toxicological analysis.
    Ferrara DS; Tedeschi L; Frison G; Brusini G
    J Chromatogr B Biomed Sci Appl; 1998 Aug; 713(1):227-43. PubMed ID: 9700561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.